APA (7th ed.) Citation

Hu, W., & Lin, C. (2023). Patients with diabetes with and without sodium-glucose cotransporter-2 inhibitors use with incident cancer risk. Journal of diabetes and its complications, 37(5), 108468. https://doi.org/10.1016/j.jdiacomp.2023.108468

Chicago Style (17th ed.) Citation

Hu, Wei-Syun, and Cheng-Li Lin. "Patients with Diabetes with and Without Sodium-glucose Cotransporter-2 Inhibitors Use with Incident Cancer Risk." Journal of Diabetes and Its Complications 37, no. 5 (2023): 108468. https://doi.org/10.1016/j.jdiacomp.2023.108468.

MLA (9th ed.) Citation

Hu, Wei-Syun, and Cheng-Li Lin. "Patients with Diabetes with and Without Sodium-glucose Cotransporter-2 Inhibitors Use with Incident Cancer Risk." Journal of Diabetes and Its Complications, vol. 37, no. 5, 2023, p. 108468, https://doi.org/10.1016/j.jdiacomp.2023.108468.